======= SOCS2 ======= == Gene Information == * **Official Symbol**: SOCS2 * **Official Name**: suppressor of cytokine signaling 2 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=8835|8835]] * **UniProt**: [[https://www.uniprot.org/uniprot/O14508|O14508]] * **Interactions**: [[https://thebiogrid.org/search.php?search=SOCS2&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20SOCS2|Open PubMed]] * **OMIM**: [[https://omim.org/entry/605117|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: SOCS family proteins form part of a classical negative feedback system that regulates cytokine signal transduction. SOCS2 appears to be a negative regulator in the growth hormone/IGF1 signaling pathway. Probable substrate recognition component of a SCF-like ECS (Elongin BC-CUL2/5-SOCS-box protein) E3 ubiquitin- protein ligase complex which mediates the ubiquitination and subsequent proteasomal degradation of target proteins. |SOCS box| |SH2| |JAK pathway signal transduction adaptor activity| |growth hormone receptor binding| |negative regulation of multicellular organism growth| |1-phosphatidylinositol-3-kinase regulator activity| |insulin-like growth factor receptor binding| |mammary gland alveolus development| |mammary gland lobule development| |interleukin-7-mediated signaling pathway| |negative regulation of receptor signaling pathway via JAK-STAT| |phosphatidylinositol 3-kinase complex| |growth hormone receptor signaling pathway| |negative regulation of receptor signaling pathway via STAT| |cellular response to growth hormone stimulus| |cellular response to interleukin-7| |response to interleukin-7| |negative regulation of insulin receptor signaling pathway| |response to growth hormone| |negative regulation of cellular response to insulin stimulus| |receptor signaling pathway via JAK-STAT| |receptor signaling pathway via STAT| |lactation| |phosphatidylinositol phosphorylation| |SH3/SH2 adaptor activity| |regulation of phosphatidylinositol 3-kinase activity| |regulation of lipid kinase activity| |regulation of insulin receptor signaling pathway| |lipid phosphorylation| |regulation of multicellular organism growth| |regulation of cellular response to insulin stimulus| |body fluid secretion| |regulation of phospholipid metabolic process| |negative regulation of developmental growth| |mammary gland development| |regulation of receptor signaling pathway via JAK-STAT| |regulation of receptor signaling pathway via STAT| |response to estradiol| |phosphatidylinositol metabolic process| |lipid modification| |negative regulation of growth| |cellular response to peptide hormone stimulus| |glycerophospholipid metabolic process| |cellular response to peptide| |regulation of developmental growth| |post-translational protein modification| |positive regulation of neuron differentiation| |phospholipid metabolic process| |glycerolipid metabolic process| |response to peptide hormone| |regulation of lipid metabolic process| |gland development| |regulation of cell growth| |positive regulation of neurogenesis| |response to peptide| |regulation of body fluid levels| |transmembrane receptor protein tyrosine kinase signaling pathway| |positive regulation of nervous system development| |positive regulation of cell development| |cellular response to organonitrogen compound| |cellular response to hormone stimulus| |regulation of neuron differentiation| |cellular response to nitrogen compound| |regulation of growth| |cytokine-mediated signaling pathway| |protein ubiquitination| |enzyme linked receptor protein signaling pathway| |protein modification by small protein conjugation| |regulation of neurogenesis| |response to lipid| |regulation of kinase activity| |organophosphate metabolic process| |negative regulation of apoptotic process| |negative regulation of programmed cell death| |response to hormone| |response to organic cyclic compound| |regulation of nervous system development| |regulation of cell development| |negative regulation of developmental process| |cellular lipid metabolic process| |positive regulation of cell differentiation| |regulation of transferase activity| |protein modification by small protein conjugation or removal| |negative regulation of cell death| |response to organonitrogen compound| |cellular response to cytokine stimulus| |cellular response to oxygen-containing compound| |response to nitrogen compound| |response to cytokine| |secretion| |negative regulation of multicellular organismal process| |lipid metabolic process| |cellular response to endogenous stimulus| |negative regulation of signal transduction| |phosphorylation| |negative regulation of cell communication| |negative regulation of signaling| |positive regulation of developmental process| |response to endogenous stimulus| |generation of neurons| |regulation of apoptotic process| |response to oxygen-containing compound| |regulation of programmed cell death| |regulation of phosphorylation| |negative regulation of response to stimulus| |neurogenesis| |positive regulation of signal transduction| |regulation of cell death| |intracellular signal transduction| |positive regulation of multicellular organismal process| |regulation of phosphate metabolic process| |regulation of phosphorus metabolic process| |regulation of cell differentiation| |positive regulation of cell communication| |positive regulation of signaling| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp518|RK-33 8μM R08 exp518]]|-1.9| ^Gene^Correlation^ |[[:human genes:p:prim1|PRIM1]]|0.536| Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 12274 * **Expression level (log2 read counts)**: 5.55 {{:chemogenomics:nalm6 dist.png?nolink |}}